Republicans Will Be Hard-Pressed To Pass Trump’s ‘Great Healthcare Plan’

A lack of Democratic cooperation and strict Senate rules threaten the legislative viability of the White House framework.

Read More

Nevada To Receive $180M To Help Bolster Rural Health Care System

Nevada was awarded nearly $180 million in federal money this week to help modernize the state’s rural health care system and bolster access to it, according to the Trump administration and state officials. “Today’s announcement highlights the Trump administration’s commitment to strengthening the rural health workforce, modernizing facilities and technology, and deploying innovative care models ...

Read More

Nevada Still Has Big Chunk Of Pandemic Funds Before ‘Use It Or Lose It’ Deadline

Agencies have one year to use all the money. Twenty projects have “spending concerns,” but the state has not publicly expressed worries about the deadline.

Read More

CMS Paying More for Medicare Advantage Patients Compared to Traditional Enrollees

The Centers for Medicare & Medicaid Services (CMS) is continuing to pay Medicare Advantage (MA) plans more — $76 billion more in 2026 — than if those same patients were enrolled in traditional fee-for-service Medicare. That higher cost comes despite a policy CMS redesigned in 2024 to limit MA plans’ ability to exaggerate patients’ health ...

Read More

PBM Transparency Mandates Added To ‘Must-Pass’ House Bill

House negotiators have put two major pharmacy benefit manager provisions in big, “must pass” spending package that’s now speeding toward a vote on the House floor. One provision in the Consolidated Appropriations Act, 2026 package would require PBMs to provide employers and other health plan sponsor fiduciaries with detailed prescription drug benefits tracking reports, to help ...

Read More

Payer CEOs Point To Hospitals, Drug Manufacturers For Rising Costs Ahead Of Congressional Hearings

The CEOs of most of the nation’s largest health insurers plan to lay blame for rising healthcare costs on hospitals, pharmaceutical companies and specialty providers during testimony before Congress on Jan. 22. In written testimonies submitted ahead of back-to-back hearings before the House Energy and Commerce Subcommittee on Health and the House Ways and Means Committee, the top executives ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square